Individualized treatment of anti-infective drugs for spinal infections
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
This study is testing how well different anti-infective drugs work for people with spinal infections to see if personalized treatments can improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Sex | All |
| Sponsor | Shandong University Academic / other |
| Locations | 1 site (Jinan) |
| Trial ID | NCT06711575 on ClinicalTrials.gov |
What this trial studies
This study aims to analyze the pharmacokinetic characteristics of anti-infective drugs in patients with suspected or confirmed spinal infections. It will evaluate the effectiveness and safety of these treatments in this specific patient population. By observing patients undergoing anti-infective therapy, the study seeks to gather data that can inform personalized treatment approaches. The observational nature of the study allows for real-world insights into drug performance in clinical settings.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with suspected or confirmed spinal infections who are currently receiving anti-infective drug therapy.
Not a fit: Patients who are pregnant or lactating, or those with other unspecified factors deemed unsuitable by researchers, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective and tailored treatment strategies for patients with spinal infections.
How similar studies have performed: While this approach is observational, similar studies in pharmacokinetics have shown promise in optimizing treatment for infectious diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy. Exclusion Criteria: * Pregnant/lactating women. * There are other factors that the researchers think are not suitable for inclusion
Where this trial is running
Jinan
- Shandong Public Health Clinical Center — Jinan, China (Recruiting)
Study contacts
- Principal investigator: Wei Zhao, Ph.D — Shandong University
- Study coordinator: Wei Zhao, Ph.D
- Email: zhao4wei2@hotmail.com
- Phone: 8653188383308
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.